Unlisted holdings
% of total assets |
---|
N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 29/02/2024
Investment | % of total assets |
---|---|
Eli Lilly and Co | 7.3 |
Zealand Pharma A/S | 5.7 |
AbbVie Inc | 5.7 |
Elevance Health Inc | 5.0 |
Novartis AG Registered Shares | 4.9 |
Abbott Laboratories | 4.4 |
Intuitive Surgical Inc | 3.6 |
Becton Dickinson & Co | 3.5 |
Essilorluxottica | 3.3 |
UCB SA | 3.3 |
Geographic breakdown
Data as at : 31/03/2024
Country | % of total assets |
---|---|
USA | 51.0 |
Switzerland | 10.0 |
Denmark | 7.0 |
France | 7.0 |
Belgium | 4.0 |
Japan | 4.0 |
UK | 4.0 |
Australia | 3.0 |
Ireland | 3.0 |
Sweden | 3.0 |
Netherlands | 2.0 |
Cayman Islands | 1.0 |
India | 1.0 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 29/02/2024
Industry | % of total assets |
---|---|
Healthcare | 107.9 |
Cash Equivalents | -7.9 |
Asset breakdown
Data as at : 29/02/2024
Asset | % of total assets |
---|---|
Stock | 107.9 |
Other | 0.0 |
Cash/Cash equivalents | -7.9 |
Detailed asset breakdown
Data as at : 29/02/2024
Asset | % of total assets |
---|---|
North America - stock | 60.3 |
Europe - Large-cap stock | 20.8 |
Europe - Mid-cap stock | 11.2 |
Japan - stock | 5.1 |
Asia (excl Japan) - stock | 4.5 |
UK - Mid core/growth stock | 1.9 |
UK - Mid core/value stock | 1.6 |
UK - Small core/growth stock | 1.4 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.